Assessment of the 90-day Mortality Risk Score After VATS Lobectomy

Università degli Studi dell'Insubria

Status: Completed

Conditions: Morality; Surgery--Complications; Lung Cancer

Treatments: Procedure: VATS lobectomy

Study type: Observational

Funder types: Other

Identifiers

NCT04799509

VALIDATION

Details and patient eligibility

About

A five classes (A-E) aggregate risk score predicting 90-day mortality after video-assisted thoracoscopic lobectomy for lung cancer, including as independent factors male sex (3 points), carbon monoxide lung diffusion capacity <60% (1 point) and operative time >150 minutes (1 point), has been recently published. This study aims to assess the effectiveness and reliability of this risk model in a large, independent cohort of patients, in order to confirm its generalizability.

Full description

From the Italian VATS Group Database, we selected patients who underwent video-assisted thoracoscopic lobectomy for non-small cell lung cancer. We calculated the aggregate risk score and the corresponding class of 90-day mortality risk for each patient. The correlation between risk classes and mortality rates was tested by Spearman's rho-test. Model calibration was evaluated by Hosmer-Lemeshow goodness-of-fit test.

Enrollment: 2,209 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients undergoing VATS lobectomy for non-small cell lung cancer

Exclusion criteria

• Incomplete data for risk score calculation
• Tumor size >5 cm
• Follow-up <3 months
• Patients undergoing neoadjuvant treatment
• Patients undergoing extended resection